...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Private placement one million plus units for US$2, half wt exercisable at US3, good for 3 years

Zenith E, just received $5 Million Usd mid January from a milestone payment from Newsoara Pharma, not sure why they need more $$ from PP, maybe a short term loan to RVX ?? where is you see the link to the PP?

Share
New Message
Please login to post a reply